Evaluation of a New Silicone Hydrogel Contact Lens

Bausch + Lomb

Status: Completed

Conditions: Myopia

Treatments: Device: Air Optix Aqua; Device: Test lens

Study type: Interventional

Funder types: Industry

Identifiers

NCT01309880

686E

Details and patient eligibility

About

The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses developed by Bausch + Lomb.

Enrollment: 66 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
• Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.

Exclusion criteria

• Have worn gas permeable (GP) contact lenses within last 30 days or polymethylmethacrylate (PMMA) lenses within last 3 months.
• Any systemic disease affecting ocular health.
• Using any systemic or topical medications that will affect ocular physiology or lens performance.
• An active ocular disease, any corneal infiltrative response or are using any ocular medications.
• Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
• Allergic to any component in the study care products.

Trial design

66 participants in 2 patient groups

Air Optix Aqua

Active Comparator group

Description:

Ciba Vision daily wear contact lens

Treatment:

Device: Air Optix Aqua

Test Lens

Experimental group

Description:

Investigational silicone hydrogel contact lens

Treatment:

Device: Test lens